These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1849973)
1. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814. Harris RA; Preston CM J Gen Virol; 1991 Apr; 72 ( Pt 4)():907-13. PubMed ID: 1849973 [TBL] [Abstract][Full Text] [Related]
2. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. Steiner I; Spivack JG; Deshmane SL; Ace CI; Preston CM; Fraser NW J Virol; 1990 Apr; 64(4):1630-8. PubMed ID: 2157048 [TBL] [Abstract][Full Text] [Related]
3. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. Jamieson DR; Robinson LH; Daksis JI; Nicholl MJ; Preston CM J Gen Virol; 1995 Jun; 76 ( Pt 6)():1417-31. PubMed ID: 7782770 [TBL] [Abstract][Full Text] [Related]
4. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. Valyi-Nagy T; Deshmane SL; Spivack JG; Steiner I; Ace CI; Preston CM; Fraser NW J Gen Virol; 1991 Mar; 72 ( Pt 3)():641-9. PubMed ID: 1848599 [TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus genes involved in latency in vitro. Russell J; Stow ND; Stow EC; Preston CM J Gen Virol; 1987 Dec; 68 ( Pt 12)():3009-18. PubMed ID: 2826646 [TBL] [Abstract][Full Text] [Related]
6. Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65. McFarlane M; Daksis JI; Preston CM J Gen Virol; 1992 Feb; 73 ( Pt 2)():285-92. PubMed ID: 1371540 [TBL] [Abstract][Full Text] [Related]
7. Neurons containing latency-associated transcripts are numerous and widespread in dorsal root ganglia following footpad inoculation of mice with herpes simplex virus type 1 mutant in1814. Ecob-Prince MS; Preston CM; Rixon FJ; Hassan K; Kennedy PG J Gen Virol; 1993 Jun; 74 ( Pt 6)():985-94. PubMed ID: 8389813 [TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus latency in tissue culture cells. Preston CM; Russell J; Harris RA; Jamieson DR Gene Ther; 1994; 1 Suppl 1():S49-50. PubMed ID: 8542396 [TBL] [Abstract][Full Text] [Related]
9. Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. Stow EC; Stow ND J Gen Virol; 1989 Mar; 70 ( Pt 3)():695-704. PubMed ID: 2543754 [TBL] [Abstract][Full Text] [Related]
10. An in vitro latency system for herpes simplex virus type 2. Russell J; Preston CM J Gen Virol; 1986 Feb; 67 ( Pt 2)():397-403. PubMed ID: 3003243 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency. Scheck AC; Wigdahl B; Rapp F Intervirology; 1989; 30(3):121-36. PubMed ID: 2473963 [TBL] [Abstract][Full Text] [Related]
12. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Tal-Singer R; Pichyangkura R; Chung E; Lasner TM; Randazzo BP; Trojanowski JQ; Fraser NW; Triezenberg SJ Virology; 1999 Jun; 259(1):20-33. PubMed ID: 10364486 [TBL] [Abstract][Full Text] [Related]
13. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Block TM; Deshmane S; Masonis J; Maggioncalda J; Valyi-Nagi T; Fraser NW Virology; 1993 Feb; 192(2):618-30. PubMed ID: 8380666 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. Valyi-Nagy T; Deshmane SL; Raengsakulrach B; Nicosia M; Gesser RM; Wysocka M; Dillner A; Fraser NW J Virol; 1992 Dec; 66(12):7336-45. PubMed ID: 1331523 [TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. Ace CI; McKee TA; Ryan JM; Cameron JM; Preston CM J Virol; 1989 May; 63(5):2260-9. PubMed ID: 2539517 [TBL] [Abstract][Full Text] [Related]
16. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. Thompson RL; Preston CM; Sawtell NM PLoS Pathog; 2009 Mar; 5(3):e1000352. PubMed ID: 19325890 [TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. Harris RA; Everett RD; Zhu XX; Silverstein S; Preston CM J Virol; 1989 Aug; 63(8):3513-5. PubMed ID: 2545921 [TBL] [Abstract][Full Text] [Related]
18. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line. Kondo Y; Yura Y; Iga H; Yanagawa T; Yoshida H; Furumoto N; Sato M Cancer Res; 1990 Dec; 50(24):7852-7. PubMed ID: 2174735 [TBL] [Abstract][Full Text] [Related]
19. Activation of latent herpes simplex virus type 2 infection in vitro requires a (E)-5-(2-bromovinyl)-2'-deoxyuridine-sensitive gene function. Scheck AC; Wigdahl B; Rapp F Intervirology; 1987; 27(3):121-9. PubMed ID: 2822602 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. Stow ND; Stow EC J Gen Virol; 1986 Dec; 67 ( Pt 12)():2571-85. PubMed ID: 3025339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]